How Oral Chelation Therapy Works, And What Diseases It Can Cure

Chelation therapy is a way to get rid of heavy metals from the blood, including lead or mercury. It’s one of the common cures for a variety of metal poisonings. Oral EDTA chelation therapy has allegedly been used to cure various illnesses, such as diabetes, heart disease, autism, and Alzheimer’s disease.

Before exploring some of its less common uses to assess its efficacy, we will first discuss how chelation treatment works.

Chelators, also known as chelating agents, are taken during chelation treatment. dimercaptosuccinic acid, Ethylenediaminetetraacetic acid (EDTA), and dimercaprol are a few popular oral Edta chelation therapy chelators. Some chelators are more effective than others at removing particular metals. Chelators function by attaching to metals in the blood. They bond to metals as they travel through the blood after being administered. Chelators gather all the heavy metals into a substance filtered by the kidneys and excreted in the urine.

Alzheimer’s disease: Based on the idea that Alzheimer’s is brought on by an accumulation of aluminum in the brain through aluminum pots and pans, water, food, and deodorant, chelation treatment is used to treat the disease. Though some academics disagree, a review of a trusted source of the available studies found no proof of a connection between aluminum exposure and Alzheimer’s disease. No matter how they are related, most chelators are too big to pass across the blood-brain barrier. This wall functions as a net to regulate what gets into and out of your brain.

Heart problem: Chelation therapy is recommended by some as a treatment for atherosclerosis, which results in a buildup of plaque in arteries and is one of the major benefits of oral chelation therapy. It may eventually result in heart disease. Chelators, according to proponents, bind to the calcium in plaque, which aids in removing and liquifying the accumulation. Although this makes sense, there isn’t much proof that chelation therapy is beneficial. For instance, small clinical research with individuals who had previously experienced a heart attack did not provide sufficient data to warrant the routine application of chelation treatment for heart disease.

Diabetes: Diabetes cannot be treated with chelation treatment. However, those who have diabetes are considerably more likely to get cardiac issues. Chelation treatment might lessen this risk. According to a subgroup study conducted in 2015 by Trusted Source, EDTA does lower the incidence of cardiac issues in individuals with diabetes but not in those without the disease. Although the primary benefits of oral chelation therapy results are encouraging, more extensive clinical trials, including for people with diabetes, are required.